Welcome to Nofinity

The transcript discusses the use of AI in medicine, highlighting a specific case from Australia: a dog with cancer was successfully treated using AI-driven genomic analysis and mRNA therapy. It criticizes Germany, Austria, and Switzerland for their hesitant AI adoption, while countries like the UAE and Singapore lead the way. The speaker emphasizes AI's potential in healthcare, warns about data privacy risks and overestimating AI, and provides a practical tip: in Gmail, smart features can be disabled to prevent Gemini from accessing personal data.

Summary follows...

Summary follows...

Summary follows...

Summary follows...

• Otis, Kone, and Schindler are defensive elevator stocks benefiting more from servicing than new installations.
• The market grows 2.9% annually and could double over the next decade.

• Stock down 40% from its peak 1.5 years ago.
• P/E ratio: 19, Dividend yield: 2.48%, Market cap: $28 billion.
• Business model: Servicing 2.5 million elevators and escalators is the core, providing stable cash flows.
• Challenges: High debt from spin-off, negative equity, and weak new equipment sales in China.
• Financial health: Adjusted free cash flow of $1.5 billion, share buybacks of $800 million.
• Valuation: Intrinsic value at $43 (assuming 6% dividend growth); current price is higher. A margin of safety appears only at $30–35 (50% drop).
• Shareholder yield: Total yield of ~5% (2.5% dividend + 3% buyback yield).

• Kone: Better stock performance, focus on dividends (no massive buybacks). Solid balance sheet (near-zero debt). Adjusted free cash flow close to $2 billion.
• Schindler: Swiss company with confirmed guidance. Valuation similar to Kone.
• Common trends: Digitalization, connectivity, and modernization reduce maintenance costs and boost efficiency.
• Competition: Otis is market leader, followed by Kone and Schindler (oligopoly).

• Strengths: Stable, predictable cash flows, oligopolistic structure, growth tailwinds from urbanization in Asia.
• Weaknesses: High valuations in current market, insufficient margin of safety for value investors.
• Recommendation: Monitor these stocks; if prices drop (e.g., Otis to $30–35), they become attractive entry points.
• For patient investors: These defensive stocks offer dividend growth – but only at the right price.

Summary follows...